ANI Pharmaceuticals (ANIP)
(Delayed Data from NSDQ)
$59.20 USD
+0.25 (0.42%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $59.32 +0.12 (0.20%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$59.20 USD
+0.25 (0.42%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $59.32 +0.12 (0.20%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth A Momentum A VGM
Zacks News
Spectrum Doubles in 3 Months: What's Driving the Rally?
by Zacks Equity Research
Spectrum (SPPI) focuses on developing pipeline candidates. The stock doubled in the last three months mainly on encouraging data from poziotinib study.
ANI Pharmaceuticals (ANIP) Catches Eye: Stock Jumps 17.7%
by Zacks Equity Research
ANI Pharmaceuticals (ANIP) shares rose nearly 18% in the last trading session, amid huge volumes.
Moving Average Crossover Alert: ANI Pharmaceuticals (ANIP)
by Zacks Equity Research
ANI Pharmaceuticals, Inc. (ANIP) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
New Strong Buy Stocks for August 9th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
This Value Screen Is Our Top Performer This Year
by Kevin Matras
See how this screen has blown past the market and how you can start using it in your own portfolio. Highlighted stocks include ANIP, KCG, MDR, POWL and RRMS.
5 Stocks With Incredible Growth Prospects
by Brian Bolan
A screen for 35% or more growth in revenue and earnings results in these picks!